AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2024
Aug 19, 2024
34519_dirs_2024-08-19_9fec33ff-b2a4-4aa5-8c04-a95c15fc5dfe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2024-08-15
Reporting Person: Tomsche David Scott (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-15 | Common stock $0.10 per value per share | D | 2017 | $3.567 | Acquired | 105623 | Direct |
| 2024-08-16 | Common stock $0.10 per value per share | D | 4811 | $3.7171 | Acquired | 110434 | Direct |
| 2024-08-19 | Common stock $0.10 per value per share | D | 3172 | $3.6700 | Acquired | 113606 | Direct |
Footnotes
F1: 1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23